Harold Bernstein, President, R&D & CMO: Maze Therapeutics MAZE Sell · Filed 03/20

Trade details

Type: Insider sale
Amount: $296,960.2
Shares · price: 6,161 sh · $48.20 a share
Held after: 8,839 sh
Stock: Maze Therapeutics MAZE
Person: Harold BernsteinPresident, R&D & CMO
Trade date: 26/03/20
Filed: 26/03/20
Days to filing: 0 days

Sold 41.1% of holdings

Share of holding sold: 41.1%

Maze Therapeutics trades, last 26 weeks

What else happened in Maze Therapeutics around then

Filed or reported within 30 days of the trade day · 02/18~04/19

Harold Bernstein's recent trades

Harold BernsteinPresident, R&D & CMO
Sell10b5-1 planMaze Therapeutics
Sell10b5-1 plan
Maze Therapeutics
MAZE
$434.7K
16,141 sh
$434.7K
Filed 10/02
Traded 10/01
Harold BernsteinPresident, R&D & CMO
Planned sale10b5-1 planMaze Therapeutics
Planned sale10b5-1 plan
Maze Therapeutics
MAZE
$438.7K
16,141 sh
$438.7K
Filed 10/01
Traded 10/01
Harold BernsteinPresident, R&D & CMO
Planned sale10b5-1 planMaze Therapeutics
Planned sale10b5-1 plan
Maze Therapeutics
MAZE
$251.1K
9,705 sh
$251.1K
Filed 09/04
Traded 09/04
Harold BernsteinPresident, R&D & CMO
Planned saleMaze Therapeutics
Planned sale
Maze Therapeutics
MAZE
$283.5K
10,685 sh
$283.5K
Filed 09/02
Traded 09/02
Harold BernsteinPresident, R&D & CMO
Planned sale10b5-1 planMaze Therapeutics
Planned sale10b5-1 plan
Maze Therapeutics
MAZE
$1.4M
46,892 sh
$1.4M
Filed 07/01
Traded 07/01

Harold Bernstein, CMO — sold $297K of Maze Therapeutics MAZE · 41.1% of holdings · 10b5-1 plan | Whalegun